Identity
HGNC
LOCATION
Xq22.2
LOCUSID
ALIAS
SIIR,WEX9,p21,pp21
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 9338
MIM: 300237
HGNC: 11616
Ensembl: ENSG00000172465
Variants:
dbSNP: 9338
ClinVar: 9338
TCGA: ENSG00000172465
COSMIC: TCEAL1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000172465 | ENST00000372624 | Q15170 |
| ENSG00000172465 | ENST00000372625 | Q15170 |
| ENSG00000172465 | ENST00000372626 | Q15170 |
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38200082 | 2024 | Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder. | 1 |
| 38200082 | 2024 | Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder. | 1 |
| 36368327 | 2022 | TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions. | 2 |
| 36368327 | 2022 | TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions. | 2 |
| 33033111 | 2020 | In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. | 10 |
| 33033111 | 2020 | In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. | 10 |
| 19475409 | 2010 | Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. | 20 |
| 19475409 | 2010 | Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. | 20 |
| 18640142 | 2008 | Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. | 5 |
| 18640142 | 2008 | Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. | 5 |
| 16331344 | 2006 | Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. | 14 |
| 16364249 | 2006 | TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer. | 10 |
| 16542834 | 2006 | Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. | 9 |
| 16697770 | 2006 | Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. | 8 |
| 16331344 | 2006 | Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. | 14 |
Citation
Dessen P
TCEAL1 (transcription elongation factor A like 1)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/46344/tceal1
